VPIM
Vanguard Personalized Indexing Management’s Intellia Therapeutics NTLA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $96.4K | Sell |
10,277
-931
| -8% | -$8.73K | ﹤0.01% | 1746 |
|
|
2025
Q1 | $79.7K | Buy |
+11,208
| New | +$79.7K | ﹤0.01% | 1641 |
|
|
2024
Q2 | – | Sell |
-8,944
| Closed | -$246K | – | 1728 |
|
|
2024
Q1 | $246K | Buy |
8,944
+2,197
| +33% | +$60.4K | 0.01% | 1360 |
|
|
2023
Q4 | $206K | Buy |
+6,747
| New | +$206K | 0.01% | 1405 |
|
|
2023
Q3 | – | Sell |
-5,854
| Closed | -$239K | – | 1535 |
|
|
2023
Q2 | $239K | Sell |
5,854
-972
| -14% | -$39.6K | 0.01% | 1249 |
|
|
2023
Q1 | $254K | Buy |
+6,826
| New | +$254K | 0.01% | 1199 |
|
|
2022
Q4 | – | Sell |
-6,546
| Closed | -$366K | – | 1311 |
|
|
2022
Q3 | $366K | Buy |
6,546
+274
| +4% | +$15.3K | 0.02% | 894 |
|
|
2022
Q2 | $325K | Buy |
6,272
+2,424
| +63% | +$126K | 0.02% | 959 |
|
|
2022
Q1 | $280K | Buy |
3,848
+1,375
| +56% | +$100K | 0.01% | 1017 |
|
|
2021
Q4 | $292K | Sell |
2,473
-1,186
| -32% | -$140K | 0.02% | 872 |
|
|
2021
Q3 | $491K | Buy |
+3,659
| New | +$491K | 0.04% | 523 |
|